Vault-13

VHCP Management III, LLC

New York, NY · CIK 1738053 · 13F filing filed 2020-02-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$503.6m reported value
18positions
90.4%in top 10
—no comparable previous quarter

Holdings, Q4 2019

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 AXSOME THERAPEUTICS INC COM AXSM AXSM 1,547,994 $160.0m31.77% 31.77% —
2 CONSTELLATION PHARMCETICLS I COM CNST CNST 2,516,242 $118.5m23.54% 23.54% —
3 MILESTONE PHARMACEUTICALS IN COM MIST MIST 2,066,529 $33.1m6.57% 6.57% —
4 RELMADA THERAPEUTICS INC COM RLMD RLMD 767,938 $29.9m5.95% 5.95% —
5 89BIO INC COM ETNB ETNB 958,765 $25.2m5.00% 5.00% —
6 10X GENOMICS INC CL A COM TXG TXG 300,000 $22.9m4.54% 4.54% —
7 FORTY SEVEN INC COM FTSV FTSV 516,381 $20.3m4.04% 4.04% —
8 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 575,000 $19.7m3.92% 3.92% —
9 IVERIC BIO INC COM OPHT OPHT 1,699,797 $14.6m2.90% 2.90% —
10 KALVISTA PHARMACEUTICALS INC COM KALV KALV 619,905 $11.0m2.19% 2.19% —
11 ADVERUM BIOTECHNOLOGIES INC COM COM 946,234 $10.9m2.16% 2.16% —
12 MARINUS PHARMACEUTICALS INC COM MRNS MRNS 5,016,164 $10.8m2.15% 2.15% —
13 MERSANA THERAPEUTICS INC COM COM 1,561,389 $8.9m1.78% 1.78% —
14 MYOVANT SCIENCES LTD COM MYOV MYOV 455,255 $7.1m1.40% 1.40% —
15 NEXTCURE INC COM COM 119,693 $6.7m1.34% 1.34% —
16 OBSEVA SA COM COM 810,264 $3.1m0.61% 0.61% —
17 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 80,929 $571.0k0.11% 0.11% —
18 BELLEROPHON THERAPEUTICS INC COM BLPH BLPH 383,955 $134.0k0.03% 0.03% —